Skip to content

Clinical translational study of supercooling-based preservation technology to extend the preservation time and improve preservation quality of donor liver

Clinical translational study of supercooling-based preservation technology to extend the preservation time and improve preservation quality of donor liver

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037195
Enrollment
Unknown
Registered
2020-08-27
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver transplantation

Interventions

Supercooling group:Supercooling preservation
Control group:UW preservation

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. End-stage liver disease; 2. The donor liver comes from brain-dead organ donations from Chinese citizens; 3. The age of the donor is between 18-60 years old, and the age of the recipient is between 18-70 years old; 4. Sign the Consent; 5. Tumors of patients with liver cancer must meet the Hangzhou criteria; 6. Receipt MELD score < 30 points.

Exclusion criteria

Exclusion criteria: 1. Retransplantation; 2. Receipt with fulminant liver failure; 3. HIV positive; 4. With serious systemic infection; 5. Multiple organ transplantation.

Design outcomes

Primary

MeasureTime frame
Liver function;

Secondary

MeasureTime frame
Liver vascular function;Serum cytokines;Coagulation function;Renal function;Pathological score;Apoptosis score;Liver ultrastructure;Immune cell infiltration;Complication rate;One-year survival;Three-year survival;

Countries

China

Contacts

Public ContactLin Zhong

Shanghai General Hospital

zhonglin1@medmail.com.cn+86 13917603139

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026